• 1
    Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 1217.
  • 2
    Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004; 25: 7584.
  • 3
    Hirsch E, Katanaev VL, Garlanda C et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 2000; 287: 104953.
  • 4
    Curnock AP, Sotsios Y, Wright KL, Ward SG. Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinases. J Immunol 2003; 170: 402130.
  • 5
    Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, Bourne HR. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 2000; 287: 103740.
  • 6
    Meili R, Firtel RA. Two poles and a compass. Cell 2003; 114: 1536.
  • 7
    Ward SG. Do phosphoinositide 3-kinases direct lymphocyte navigation? Trends Immunol 2004; 25: 6774.
  • 8
    Fukui Y, Hashimoto O, Sanui T et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001; 412: 82631.
  • 9
    Weber KS, Klickstein LB, Wever PC, Weber C. Chemokine-induced monocyte transmigration requires cdc42-mediated cytoskeletal changes. Eur J Immunol 1998; 28: 224551.
  • 10
    Li Z, Hannigan M, Mo Z et al. Directional sensing requires G βγ-mediated PAK1 and PIX α-dependent activation of Cdc42. Cell 2003; 114: 21527.
  • 11
    Xu J, Wang F, Keymeulen AV et al. Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 2003; 114: 20114.
  • 12
    Shimonaka M, Katagiri K, Nakayama T et al. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol 2003; 161: 41727.
  • 13
    Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003; 4: 7418.
  • 14
    Katagiri K, Ohnishi N, Kabashima K et al. Critical functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol 2004; 5: 104551.
  • 15
    Yang TY, Chen SC, Leach MW et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 2000; 191: 44554.
  • 16
    Payne AS, Cornelius L. A, The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 2002; 118: 91522.
  • 17
    Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 32427.
  • 18
    Varney ML, Li A, Dave BJ, Bucana CD, Johansson SL, Singh RK. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis 2003; 20: 72331.
  • 19
    Norgauer J, Metzner B, Schraufstatter I. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 1996; 156: 11327.
  • 20
    Arya M, Patel HR, Williamson M. Chemokines: key players in cancer. Curr Med Res Opin 2003; 19: 55764.
  • 21
    Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277: 494817.
  • 22
    Kawada K, Sonoshita M, Sakashita H et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 2004; 64: 40107.
  • 23
    Strieter RM, Polverini PJ, Kunkel SL et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 2734857.
  • 24
    Ferrer FA, Miller LJ, Andrawis RI et al. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998; 51: 1617.
  • 25
    Veltri RW, Miller MC, Zhao G et al. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology 1999; 53: 13947.
  • 26
    Uehara H, Troncoso P, Johnston D et al. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate 2005; 64: 409.
  • 27
    Moore BB, Arenberg DA, Stoy K et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999; 154: 150312.
  • 28
    Smith DR, Polverini PJ, Kunkel SL et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994; 179: 140915.
  • 29
    Strieter RM, Polverini PJ, Arenberg DA et al. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995; 57: 75262.
  • 30
    Arenberg DA, Kunkel SL, Polverini PJ et al. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996; 184: 98192.
  • 31
    Sgadari C, Angiolillo AL, Cherney BW et al. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci USA 1996; 93: 137916.
  • 32
    Luboshits G, Shina S, Kaplan O et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 1999; 59: 46817.
  • 33
    Robinson SC, Scott KA, Wilson JL, Thompson RG, Proudfoot AE, Balkwill FR. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 2003; 63: 83605.
  • 34
    Ohta M, Kitadai Y, Tanaka S et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002; 102: 2204.
  • 35
    Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193: 72739.
  • 36
    Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2002; 7: 14762.
  • 37
    Monti P, Leone BE, Marchesi F et al. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res 2003; 63: 745161.
  • 38
    Bell D, Chomarat P, Broyles D et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999; 190: 141726.
  • 39
    Zou W, Machelon V, Coulomb-L’Hermin A et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001; 7: 133946.
  • 40
    Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002; 13: 14354.
  • 41
    Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 506.
  • 42
    Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004; 14: 1719.
  • 43
    Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004; 4: 54050.
  • 44
    Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol 2004; 14: 1815.
  • 45
    Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001; 93: 163843.
  • 46
    Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004; 4: 36070.
  • 47
    Cavanagh LL, Von Andrian UH. Travellers in many guises: the origins and destinations of dendritic cells. Immunol Cell Biol 2002; 80: 44862.
  • 48
    Mashino K, Sadanaga N, Yamaguchi H et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002; 62: 293741.
  • 49
    Ding Y, Shimada Y, Maeda M et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 2003; 9: 340612.
  • 50
    Ishida T, Utsunomiya A, Iida S et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 362534.
  • 51
    Kleinhans M, Tun-Kyi A, Gilliet M et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2003; 101: 148793.
  • 52
    Kuschert GS, Coulin F, Power CA et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 1999; 38: 1295968.
  • 53
    Kawashima H, Atarashi K, Hirose M et al. Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1–3GalNAc (4,6-O-disulfate) interact with L- and P-selectin and chemokines. J Biol Chem 2002; 277: 1292130.
  • 54
    Rot A, Von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891928.
  • 55
    Pelletier AJ, Van Der Laan LJ, Hildbrand P et al. Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells. Blood 2000; 96: 268290.
  • 56
    Nagakubo D, Murai T, Tanaka T et al. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol 2003; 171: 55361.
  • 57
    Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, Scadden DT. Active movement of T cells away from a chemokine. Nat Med 2000; 6: 5438.
  • 58
    Bertolini F, Dell’Agnola C, Mancuso P et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 2002; 62: 310612.
  • 59
    Rubin JB, Kung AL, Klein RS et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Nat Acad Sci USA 2003; 100: 135138.